A Retrospective study analysing risk of serious bleeding complications from select spine interventions while continuing medications with antiplatelet or anticoagulant
Latest Information Update: 03 Jun 2021
Price :
$35 *
At a glance
- Drugs Apixaban (Primary) ; Aspirin (Primary) ; Celecoxib (Primary) ; Clopidogrel (Primary) ; Dabigatran etexilate (Primary) ; Fondaparinux sodium (Primary) ; Meloxicam (Primary) ; Warfarin (Primary)
- Indications Blood coagulation disorders
- Focus Adverse reactions
- 03 Jun 2021 New trial record